Articles

Wilimski, R.; Budzianowski, J.; Łomiak, M.; Olasińska‑Wiśniewska, A.; Pieniak, K.; Jędrzejczyk, S.; Domaszk, O.; Chudzik, M.; J. Filipiak, K.; Hiczkiewicz, J.; et al. Extracellular vesicles to predict outcomes after transcatheter aortic valve implantation – a prospective, multicenter cohort study. J. Cardiovasc. Transl. Res., in press.

Wilimski R, Budzianowski J, Łomiak M, et al. Extracellular vesicles to predict outcomes after transcatheter aortic valve implantation – a prospective, multicenter cohort study. J Cardiovasc Transl Res. In press.

R. Wilimski et al., “Extracellular vesicles to predict outcomes after transcatheter aortic valve implantation – a prospective, multicenter cohort study,” J. Cardiovasc. Transl. Res., in press.

Wilimski R, Budzianowski J, Łomiak M, Olasińska‑Wiśniewska A, Pieniak K, Jędrzejczyk S, et al. Extracellular vesicles to predict outcomes after transcatheter aortic valve implantation – a prospective, multicenter cohort study. J Cardiovasc Transl Res. In press.

Tacconi, S.; Var, F.; Sbarigia, C.; Vardanyan, D.; Longo, S.; Mura, F.; Angilè, F.; Jalabert, A.; Blangero, F.; Eljaafari, A.; et al. M1-derived extracellular vesicles polarize recipient macrophages into M2-like macrophages and alter skeletal muscle homeostasis in a hyper-glucose environment. Cell Commun. Signal. 2024, 22 (193), 723.

Tacconi S, Var F, Sbarigia C, et al. M1-derived extracellular vesicles polarize recipient macrophages into M2-like macrophages and alter skeletal muscle homeostasis in a hyper-glucose environment. Cell Commun Signal. 2024;22(193):723.

S. Tacconi et al., “M1-derived extracellular vesicles polarize recipient macrophages into M2-like macrophages and alter skeletal muscle homeostasis in a hyper-glucose environment,” Cell Commun. Signal., vol. 22, no. 193, pp. 723, Mar. 2024.

Tacconi S, Var F, Sbarigia C, Vardanyan D, Longo S, Mura F, et al. M1-derived extracellular vesicles polarize recipient macrophages into M2-like macrophages and alter skeletal muscle homeostasis in a hyper-glucose environment. Cell Commun Signal. 2024 Mar;22(193):723.

Welsh, J. A.; Goberdhan, D. C. I.; O'Driscoll, L.; Buzas, E. I.; Blenkiron, C.; Bussolati, B.; Cai, H.; Di Vizio, D.; Driedonks, T. A. P.; Erdbrügger, U.; et al. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J. Extracell. Vesicles 2024, 13 (2), e12404.

Welsh JA, Goberdhan DCI, O'Driscoll L, et al. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell Vesicles. 2024;13(2):e12404.

J. A. Welsh et al., “Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches,” J. Extracell. Vesicles, vol. 13, no. 2, pp. e12404, Feb. 2024.

Welsh JA, Goberdhan DCI, O'Driscoll L, Buzas EI, Blenkiron C, Bussolati B, et al. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell Vesicles. 2024 Feb;13(2):e12404.

Shahsavari, M.; Nieuwland, R.; van Leeuwen, T. G.; van der Pol, E. Poloxamer-188 as a wetting agent for microfluidic resistive pulse sensing measurements of extracellular vesicles. Plos One 2024, 19 (5), e0295849.

Shahsavari M, Nieuwland R, van Leeuwen TG, van der Pol E. Poloxamer-188 as a wetting agent for microfluidic resistive pulse sensing measurements of extracellular vesicles. Plos One. 2024;19(5):e0295849.

M. Shahsavari, R. Nieuwland, T. G. van Leeuwen, and E. van der Pol, “Poloxamer-188 as a wetting agent for microfluidic resistive pulse sensing measurements of extracellular vesicles,” Plos One, vol. 19, no. 5, pp. e0295849, Feb. 2024.

Shahsavari M, Nieuwland R, van Leeuwen TG, van der Pol E. Poloxamer-188 as a wetting agent for microfluidic resistive pulse sensing measurements of extracellular vesicles. Plos One. 2024 Feb;19(5):e0295849.

Marlęga-Linert, J.; Gąsecka, A.; van der Pol, E.; Kuchta, A.; Filipiak, K. J.; Fijałkowski, M.; Gruchała, M.; Nieuwland, R.; Mickiewicz, A. Lipoprotein apheresis affects the concentration of extracellular vesicles in patients with elevated lipoprotein (a). Sci. Rep. 2024, 14, 2762.

Marlęga-Linert J, Gąsecka A, van der Pol E, et al. Lipoprotein apheresis affects the concentration of extracellular vesicles in patients with elevated lipoprotein (a). Sci Rep. 2024;14:2762.

J. Marlęga-Linert et al., “Lipoprotein apheresis affects the concentration of extracellular vesicles in patients with elevated lipoprotein (a),” Sci. Rep., vol. 14, pp. 2762, Feb. 2024.

Marlęga-Linert J, Gąsecka A, van der Pol E, Kuchta A, Filipiak KJ, Fijałkowski M, et al. Lipoprotein apheresis affects the concentration of extracellular vesicles in patients with elevated lipoprotein (a). Sci Rep. 2024 Feb;14:2762.

Waury, K.; Gogishvili, D.; Nieuwland, R.; Chatterjee, M.; Teunissen, C. E.; Abeln, S. Proteome encoded determinants of protein sorting into extracellular vesicles. J. Extracell. Biol. 2024, 3 (1), e120.

Waury K, Gogishvili D, Nieuwland R, Chatterjee M, Teunissen CE, Abeln S. Proteome encoded determinants of protein sorting into extracellular vesicles. J Extracell Biol. 2024;3(1):e120.

K. Waury, D. Gogishvili, R. Nieuwland, M. Chatterjee, C. E. Teunissen, and S. Abeln, “Proteome encoded determinants of protein sorting into extracellular vesicles,” J. Extracell. Biol., vol. 3, no. 1, pp. e120, Jan. 2024.

Waury K, Gogishvili D, Nieuwland R, Chatterjee M, Teunissen CE, Abeln S. Proteome encoded determinants of protein sorting into extracellular vesicles. J Extracell Biol. 2024 Jan;3(1):e120.

Sandau, U. S.; Magaña, S. M.; Costa, J.; Nolan, J. P.; Ikezu, T.; Vella, L. J.; Jackson, H. K.; Moreira, L. R.; Palacio, P. L.; Hill, A. F.; et al. Recommendations for reproducibility of cerebrospinal fluid extracellular vesicle studies. J. Extracell. Vesicles 2024, 13 (1), 12397.

Sandau US, Magaña SM, Costa J, et al. Recommendations for reproducibility of cerebrospinal fluid extracellular vesicle studies. J Extracell Vesicles. 2024;13(1):12397.

U. S. Sandau et al., “Recommendations for reproducibility of cerebrospinal fluid extracellular vesicle studies,” J. Extracell. Vesicles, vol. 13, no. 1, pp. 12397, Jan. 2024.

Sandau US, Magaña SM, Costa J, Nolan JP, Ikezu T, Vella LJ, et al. Recommendations for reproducibility of cerebrospinal fluid extracellular vesicle studies. J Extracell Vesicles. 2024 Jan;13(1):12397.

Nieuwland, R.; Siljander, P. R. A beginner’s guide to study extracellular vesicles in human blood plasma and serum. J. Extracell. Vesicles 2024, 13 (1), e12400.

Nieuwland R, Siljander PR. A beginner’s guide to study extracellular vesicles in human blood plasma and serum. J Extracell Vesicles. 2024;13(1):e12400.

R. Nieuwland, and P. R. Siljander, “A beginner’s guide to study extracellular vesicles in human blood plasma and serum,” J. Extracell. Vesicles, vol. 13, no. 1, pp. e12400, Jan. 2024.

Nieuwland R, Siljander PR. A beginner’s guide to study extracellular vesicles in human blood plasma and serum. J Extracell Vesicles. 2024 Jan;13(1):e12400.

Deumer, J.; Schürmann, R.; Gaál, A.; Varga, Z.; Bettin, B.; van der Pol, E.; Nieuwland, R.; Ojeda, D.; Sikora, A.; Bartczak, D.; et al. Traceable characterization of hollow organosilica beads as potential reference materials for extracellular vesicle measurements with optical techniques. Disc. Nano 2024, 19 (1), 14.

Deumer J, Schürmann R, Gaál A, et al. Traceable characterization of hollow organosilica beads as potential reference materials for extracellular vesicle measurements with optical techniques. Disc Nano. 2024;19(1):14.

J. Deumer et al., “Traceable characterization of hollow organosilica beads as potential reference materials for extracellular vesicle measurements with optical techniques,” Disc. Nano, vol. 19, no. 1, pp. 14, Jan. 2024.

Deumer J, Schürmann R, Gaál A, Varga Z, Bettin B, van der Pol E, et al. Traceable characterization of hollow organosilica beads as potential reference materials for extracellular vesicle measurements with optical techniques. Disc Nano. 2024 Jan;19(1):14.

Nieuwland, R.; Enciso-Martinez, A.; Bracht, J. W. Clinical applications and challenges in the field of extracellular vesicles. Med. Genet. 2023, 35 (4), 251-258.

Nieuwland R, Enciso-Martinez A, Bracht JW. Clinical applications and challenges in the field of extracellular vesicles. Med Genet. 2023;35(4):251-258.

R. Nieuwland, A. Enciso-Martinez, and J. W. Bracht, “Clinical applications and challenges in the field of extracellular vesicles,” Med. Genet., vol. 35, no. 4, pp. 251-258, Dec. 2023.

Nieuwland R, Enciso-Martinez A, Bracht JW. Clinical applications and challenges in the field of extracellular vesicles. Med Genet. 2023 Dec;35(4):251-258.

Lucien, F.; Gustafson, D.; Lenassi, M.; Li, B.; Teske, J. J.; Boilard, E.; , o. H. K. C.; , a. J. M.; Gualerzi, A.; Reale, A.; et al. MIBlood-EV: Minimal information to enhance the quality and reproducibility of blood extracellular vesicle research. J. Extracell. Vesicles 2023, 12 (12), 12385.

Lucien F, Gustafson D, Lenassi M, et al. MIBlood-EV: Minimal information to enhance the quality and reproducibility of blood extracellular vesicle research. J Extracell Vesicles. 2023;12(12):12385.

F. Lucien et al., “MIBlood-EV: Minimal information to enhance the quality and reproducibility of blood extracellular vesicle research,” J. Extracell. Vesicles, vol. 12, no. 12, pp. 12385, Dec. 2023.

Lucien F, Gustafson D, Lenassi M, Li B, Teske JJ, Boilard E, et al. MIBlood-EV: Minimal information to enhance the quality and reproducibility of blood extracellular vesicle research. J Extracell Vesicles. 2023 Dec;12(12):12385.

Ernault, A. C.; de Winter, R.; Fabrizi, B.; Bracht, J. W.; Hau, C.; van Amersfoorth, S. C.; Meulendijks, E. R.; Tijsen, A. J.; Ortega, L. C.; van der Made, I.; et al. MicroRNAs in extracellular vesicles released from epicardial adipose tissue promote arrhythmogenic conduction slowing. Heart Rhythm O2 2023, 4 (12), 805-814.

Ernault AC, de Winter R, Fabrizi B, et al. MicroRNAs in extracellular vesicles released from epicardial adipose tissue promote arrhythmogenic conduction slowing. Heart Rhythm O2. 2023;4(12):805-814.

A. C. Ernault et al., “MicroRNAs in extracellular vesicles released from epicardial adipose tissue promote arrhythmogenic conduction slowing,” Heart Rhythm O2, vol. 4, no. 12, pp. 805-814, Dec. 2023.

Ernault AC, de Winter R, Fabrizi B, Bracht JW, Hau C, van Amersfoorth SC, et al. MicroRNAs in extracellular vesicles released from epicardial adipose tissue promote arrhythmogenic conduction slowing. Heart Rhythm O2. 2023 Dec;4(12):805-14.

Sloos, P. H.; W. Maas, M. A.; Meijers, J. C.; Nieuwland, R.; Roelofs, J. J.; Juffermans, N. P.; Kleinveld, D. J. Anti-high-mobility group box-1 treatment strategies improve trauma-induced coagulopathy in a mouse model of trauma and shock. Brit. J. Anaesth. 2023, 130 (6), 687-697.

Sloos PH, W. Maas MA, Meijers JC, et al. Anti-high-mobility group box-1 treatment strategies improve trauma-induced coagulopathy in a mouse model of trauma and shock. Brit J Anaesth. 2023;130(6):687-697.

P. H. Sloos et al., “Anti-high-mobility group box-1 treatment strategies improve trauma-induced coagulopathy in a mouse model of trauma and shock,” Brit. J. Anaesth., vol. 130, no. 6, pp. 687-697, Jun. 2023.

Sloos PH, W. Maas MA, Meijers JC, Nieuwland R, Roelofs JJ, Juffermans NP, et al. Anti-high-mobility group box-1 treatment strategies improve trauma-induced coagulopathy in a mouse model of trauma and shock. Brit J Anaesth. 2023 Jun;130(6):687-697.

Bettin, B.; van der Pol, E.; Nieuwland, R. Plasma extracellular vesicle test sample to standardize flow cytometry measurements. Res. Pract. Thromb. Haemost. 2023, 7 (4), 100181.

Bettin B, van der Pol E, Nieuwland R. Plasma extracellular vesicle test sample to standardize flow cytometry measurements. Res Pract Thromb Haemost. 2023;7(4):100181.

B. Bettin, E. van der Pol, and R. Nieuwland, “Plasma extracellular vesicle test sample to standardize flow cytometry measurements,” Res. Pract. Thromb. Haemost., vol. 7, no. 4, pp. 100181, May. 2023.

Bettin B, van der Pol E, Nieuwland R. Plasma extracellular vesicle test sample to standardize flow cytometry measurements. Res Pract Thromb Haemost. 2023 May;7(4):100181.

Dhondt, B.; Pinheiro, C.; Geeurickx, E.; Tulkens, J.; Vergauwen, G.; van der Pol, E.; Nieuwland, R.; Decock, A.; Miinalainen, I.; Rappu, P.; et al. Benchmarking blood collection tubes and processing intervals for extracellular vesicle performance metrics. J. Extracell. Vesicles 2023, 12 (5), 12315.

Dhondt B, Pinheiro C, Geeurickx E, et al. Benchmarking blood collection tubes and processing intervals for extracellular vesicle performance metrics. J Extracell Vesicles. 2023;12(5):12315.

B. Dhondt et al., “Benchmarking blood collection tubes and processing intervals for extracellular vesicle performance metrics,” J. Extracell. Vesicles, vol. 12, no. 5, pp. 12315, May. 2023.

Dhondt B, Pinheiro C, Geeurickx E, Tulkens J, Vergauwen G, van der Pol E, et al. Benchmarking blood collection tubes and processing intervals for extracellular vesicle performance metrics. J Extracell Vesicles. 2023 May;12(5):12315.

Buntsma, N. C.; Shahsavari, M.; Gąsecka, A.; Nieuwland, R.; van Leeuwen, T. G.; van der Pol, E. Preventing swarm detection in extracellular vesicle flow cytometry - a clinically applicable procedure. Res. Pract. Thromb. Haemost. 2023, 7 (4), 100171.

Buntsma NC, Shahsavari M, Gąsecka A, Nieuwland R, van Leeuwen TG, van der Pol E. Preventing swarm detection in extracellular vesicle flow cytometry - a clinically applicable procedure. Res Pract Thromb Haemost. 2023;7(4):100171.

N. C. Buntsma, M. Shahsavari, A. Gąsecka, R. Nieuwland, T. G. van Leeuwen, and E. van der Pol, “Preventing swarm detection in extracellular vesicle flow cytometry - a clinically applicable procedure,” Res. Pract. Thromb. Haemost., vol. 7, no. 4, pp. 100171, May. 2023.

Buntsma NC, Shahsavari M, Gąsecka A, Nieuwland R, van Leeuwen TG, van der Pol E. Preventing swarm detection in extracellular vesicle flow cytometry - a clinically applicable procedure. Res Pract Thromb Haemost. 2023 May;7(4):100171.

Bettin, B.; Varga, Z.; Nieuwland, R.; van der Pol, E. Standardization of extracellular vesicle concentration measurements by flow cytometry: the past, present and future. J. Thromb. Haemost. 2023, 21 (8), 2032-2044.

Bettin B, Varga Z, Nieuwland R, van der Pol E. Standardization of extracellular vesicle concentration measurements by flow cytometry: the past, present and future. J Thromb Haemost. 2023;21(8):2032-2044.

B. Bettin, Z. Varga, R. Nieuwland, and E. van der Pol, “Standardization of extracellular vesicle concentration measurements by flow cytometry: the past, present and future,” J. Thromb. Haemost., vol. 21, no. 8, pp. 2032-2044, May. 2023.

Bettin B, Varga Z, Nieuwland R, van der Pol E. Standardization of extracellular vesicle concentration measurements by flow cytometry: the past, present and future. J Thromb Haemost. 2023 May;21(8):2032-44.

Sachetto, A. T.; Archibald, S. J.; Hisada, Y.; Rosell, A.; Havervall, S.; van Es, N.; Nieuwland, R.; Campbell, R. A.; Middleton, E. A.; Rondina, M. T.; et al. Tissue factor activity of small and large extracellular vesicles in different diseases. Res. Pract. Thromb. Haemost. 2023, 7 (3), 100124.

Sachetto AT, Archibald SJ, Hisada Y, et al. Tissue factor activity of small and large extracellular vesicles in different diseases. Res Pract Thromb Haemost. 2023;7(3):100124.

A. T. Sachetto et al., “Tissue factor activity of small and large extracellular vesicles in different diseases,” Res. Pract. Thromb. Haemost., vol. 7, no. 3, pp. 100124, Mar. 2023.

Sachetto AT, Archibald SJ, Hisada Y, Rosell A, Havervall S, van Es N, et al. Tissue factor activity of small and large extracellular vesicles in different diseases. Res Pract Thromb Haemost. 2023 Mar;7(3):100124.

Wu, L.; Woud, W. W.; Baan, C. C.; Hesselink, D. A.; van der Pol, E.; Jenster, G.; Boer, K. Isolation-free measurement of single urinary extracellular vesicles by imaging flow cytometry. Nanomed. Nanotechnol. 2023, 48, 102638.

Wu L, Woud WW, Baan CC, et al. Isolation-free measurement of single urinary extracellular vesicles by imaging flow cytometry. Nanomed Nanotechnol. 2023;48:102638.

L. Wu et al., “Isolation-free measurement of single urinary extracellular vesicles by imaging flow cytometry,” Nanomed. Nanotechnol., vol. 48, pp. 102638, Feb. 2023.

Wu L, Woud WW, Baan CC, Hesselink DA, van der Pol E, Jenster G, et al. Isolation-free measurement of single urinary extracellular vesicles by imaging flow cytometry. Nanomed Nanotechnol. 2023 Feb;48:102638.

Welsh, J. A.; Arkesteijn, G. J. A.; Bremer, M.; Cimorelli, M.; Dignat-George, F.; Giebel, B.; Görgens, A.; Hendrix, A.; Kuiper, M.; Lacroix, R.; et al. A compendium of single extracellular vesicle flow cytometry. J. Extracell. Vesicles 2023, 12 (2), 12299.

Welsh JA, Arkesteijn GJA, Bremer M, et al. A compendium of single extracellular vesicle flow cytometry. J Extracell Vesicles. 2023;12(2):12299.

J. A. Welsh et al., “A compendium of single extracellular vesicle flow cytometry,” J. Extracell. Vesicles, vol. 12, no. 2, pp. 12299, Jan. 2023.

Welsh JA, Arkesteijn GJA, Bremer M, Cimorelli M, Dignat-George F, Giebel B, et al. A compendium of single extracellular vesicle flow cytometry. J Extracell Vesicles. 2023 Jan;12(2):12299.

Bracht, J. W.; Los, M.; van Eijndhoven, M. A.; Bettin, B.; van der Pol, E.; Pegtel, D. M.; Nieuwland, R. Platelet removal from human blood plasma improves detection of extracellular vesicle-associated miRNA. J. Extracell. Vesicles 2023, 12 (2), 12302.

Bracht JW, Los M, van Eijndhoven MA, et al. Platelet removal from human blood plasma improves detection of extracellular vesicle-associated miRNA. J Extracell Vesicles. 2023;12(2):12302.

J. W. Bracht et al., “Platelet removal from human blood plasma improves detection of extracellular vesicle-associated miRNA,” J. Extracell. Vesicles, vol. 12, no. 2, pp. 12302, Feb. 2023.

Bracht JW, Los M, van Eijndhoven MA, Bettin B, van der Pol E, Pegtel DM, et al. Platelet removal from human blood plasma improves detection of extracellular vesicle-associated miRNA. J Extracell Vesicles. 2023 Feb;12(2):12302.

Davidson, S. M.; Boulanger, C. M.; Aikawa, E.; Badimon, L.; Barile, L.; Binder, C. J.; Brisson, A.; Buzas, E.; Emanueli, C.; Jansen, F.; et al. Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles. Cardiovasc. Res. 2023, 119 (1), 45-63.

Davidson SM, Boulanger CM, Aikawa E, et al. Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles. Cardiovasc Res. 2023;119(1):45-63.

S. M. Davidson et al., “Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles,” Cardiovasc. Res., vol. 119, no. 1, pp. 45-63, Jan. 2023.

Davidson SM, Boulanger CM, Aikawa E, Badimon L, Barile L, Binder CJ, et al. Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles. Cardiovasc Res. 2023 Jan;119(1):45-63.

Gankema, A. A. F.; Li, B.; Nieuwland, R.; van der Pol, E. Automated fluorescence gating and size determination reduce variation in measured concentration of extracellular vesicles by flow cytometry. Cytom. Part A 2022, 101 (12), 1049-1056.

Gankema AAF, Li B, Nieuwland R, van der Pol E. Automated fluorescence gating and size determination reduce variation in measured concentration of extracellular vesicles by flow cytometry. Cytom Part A. 2022;101(12):1049-1056.

A. A. F. Gankema, B. Li, R. Nieuwland, and E. van der Pol, “Automated fluorescence gating and size determination reduce variation in measured concentration of extracellular vesicles by flow cytometry,” Cytom. Part A, vol. 101, no. 12, pp. 1049-1056, Dec. 2022.

Gankema AAF, Li B, Nieuwland R, van der Pol E. Automated fluorescence gating and size determination reduce variation in measured concentration of extracellular vesicles by flow cytometry. Cytom Part A. 2022 Dec;101(12):1049-56.

Dujardin, R. W.; Kisters, J. E.; Wirtz, M. R.; Hajji, N.; Tuip-de Boer, A. M.; Stensballe, J.; Johansson, P. I.; Brohi, K.; Davenport, R. A.; Gaarder, C.; et al. Shock-driven endotheliopathy in trauma patients is associated with leucocyte derived extracellular vesicles. Int. J. Mol. Sci. 2022, 23 (24), 15990.

Dujardin RW, Kisters JE, Wirtz MR, et al. Shock-driven endotheliopathy in trauma patients is associated with leucocyte derived extracellular vesicles. Int J Mol Sci. 2022;23(24):15990.

R. W. Dujardin et al., “Shock-driven endotheliopathy in trauma patients is associated with leucocyte derived extracellular vesicles,” Int. J. Mol. Sci., vol. 23, no. 24, pp. 15990, Dec. 2022.

Dujardin RW, Kisters JE, Wirtz MR, Hajji N, Tuip-de Boer AM, Stensballe J, et al. Shock-driven endotheliopathy in trauma patients is associated with leucocyte derived extracellular vesicles. Int J Mol Sci. 2022 Dec;23(24):15990.

Pan, W.; Feng, J.; Luo, T.; Tan, Y.; Situ, B.; Nieuwland, R.; Guo, J.; Liu, C.; Zhang, H.; Chen, J.; et al. Rapid and efficient isolation platform for plasma extracellular vesicles: EV-FISHER. J. Extracell. Vesicles 2022, 11 (11), e12281.

Pan W, Feng J, Luo T, et al. Rapid and efficient isolation platform for plasma extracellular vesicles: EV-FISHER. J Extracell Vesicles. 2022;11(11):e12281.

W. Pan et al., “Rapid and efficient isolation platform for plasma extracellular vesicles: EV-FISHER,” J. Extracell. Vesicles, vol. 11, no. 11, pp. e12281, . 2022.

Pan W, Feng J, Luo T, Tan Y, Situ B, Nieuwland R, et al. Rapid and efficient isolation platform for plasma extracellular vesicles: EV-FISHER. J Extracell Vesicles. 2022 ;11(11):e12281.

Bettin, B.; Gasecka, A.; Li, B.; Dhondt, B.; Hendrix, A.; Nieuwland, R.; van der Pol, E. Removal of platelets from blood plasma to improve the quality of extracellular vesicle research. J. Thromb. Haemost. 2022, 20 (11), 2679-2685.

Bettin B, Gasecka A, Li B, et al. Removal of platelets from blood plasma to improve the quality of extracellular vesicle research. J Thromb Haemost. 2022;20(11):2679-2685.

B. Bettin et al., “Removal of platelets from blood plasma to improve the quality of extracellular vesicle research,” J. Thromb. Haemost., vol. 20, no. 11, pp. 2679-2685, Nov. 2022.

Bettin B, Gasecka A, Li B, Dhondt B, Hendrix A, Nieuwland R, et al. Removal of platelets from blood plasma to improve the quality of extracellular vesicle research. J Thromb Haemost. 2022 Nov;20(11):2679-85.

Hu, Y.; Repa, A.; Lisman, T.; Yerlikaya-Schatten, G.; Hau, C.; Pabinger, I.; Ay, C.; Nieuwland, R.; Thaler, J. Extracellular vesicles from amniotic fluid, milk, saliva, and urine expose complexes of tissue factor and activated factor VII. J. Thromb. Haemost. 2022, 20 (10), 2306-2312.

Hu Y, Repa A, Lisman T, et al. Extracellular vesicles from amniotic fluid, milk, saliva, and urine expose complexes of tissue factor and activated factor VII. J Thromb Haemost. 2022;20(10):2306-2312.

Y. Hu et al., “Extracellular vesicles from amniotic fluid, milk, saliva, and urine expose complexes of tissue factor and activated factor VII,” J. Thromb. Haemost., vol. 20, no. 10, pp. 2306-2312, Oct. 2022.

Hu Y, Repa A, Lisman T, Yerlikaya-Schatten G, Hau C, Pabinger I, et al. Extracellular vesicles from amniotic fluid, milk, saliva, and urine expose complexes of tissue factor and activated factor VII. J Thromb Haemost. 2022 Oct;20(10):2306-2312.

Hu, Y.; Scharrer, A.; Hau, C.; Ay, C.; Berckmans, R. J.; Ruf, W.; Niuewland, R.; Thaler, J. Coagulation signaling from amniotic fluid to fetal skin. Blood Adv. 2022, 6 (19), 5538-5541.

Hu Y, Scharrer A, Hau C, et al. Coagulation signaling from amniotic fluid to fetal skin. Blood Adv. 2022;6(19):5538-5541.

Y. Hu et al., “Coagulation signaling from amniotic fluid to fetal skin,” Blood Adv., vol. 6, no. 19, pp. 5538-5541, Oct. 2022.

Hu Y, Scharrer A, Hau C, Ay C, Berckmans RJ, Ruf W, et al. Coagulation signaling from amniotic fluid to fetal skin. Blood Adv. 2022 Oct;6(19):5538-5541.

Kuiper, M.; Koops, R.; Nieuwland, R.; van der Pol, E. Method to traceably determine the refractive index by measuring the angle of minimum deviation. Metrologia 2022, 59 (5), 055006.

Kuiper M, Koops R, Nieuwland R, van der Pol E. Method to traceably determine the refractive index by measuring the angle of minimum deviation. Metrologia. 2022;59(5):055006.

M. Kuiper, R. Koops, R. Nieuwland, and E. van der Pol, “Method to traceably determine the refractive index by measuring the angle of minimum deviation,” Metrologia, vol. 59, no. 5, pp. 055006, Sep. 2022.

Kuiper M, Koops R, Nieuwland R, van der Pol E. Method to traceably determine the refractive index by measuring the angle of minimum deviation. Metrologia. 2022 Sep;59(5):055006.

Buntsma, N. C.; Gąsecka, A.; Roos, Y. B.; Leeuwen, T. G.; van der Pol, E.; Nieuwland, R. EDTA stabilizes the concentration of platelet-derived extracellular vesicles during blood collection and handling. Platelets 2022, 33 (5), 764-771.

Buntsma NC, Gąsecka A, Roos YB, Leeuwen TG, van der Pol E, Nieuwland R. EDTA stabilizes the concentration of platelet-derived extracellular vesicles during blood collection and handling. Platelets. 2022;33(5):764-771.

N. C. Buntsma, A. Gąsecka, Y. B. Roos, T. G. Leeuwen, E. van der Pol, and R. Nieuwland, “EDTA stabilizes the concentration of platelet-derived extracellular vesicles during blood collection and handling,” Platelets, vol. 33, no. 5, pp. 764-771, Jul. 2022.

Buntsma NC, Gąsecka A, Roos YB, Leeuwen TG, van der Pol E, Nieuwland R. EDTA stabilizes the concentration of platelet-derived extracellular vesicles during blood collection and handling. Platelets. 2022 Jul;33(5):764-71.

Woud, W. W.; van der Pol, E.; Mul, E.; Hoogduijn, M. J.; Baan, C. C.; Boer, K.; Merino, A. An imaging flow cytometry-based methodology for the analysis of single extracellular vesicles in unprocessed human plasma. Commun. Biol. 2022, 5 (633), 1-14.

Woud WW, van der Pol E, Mul E, et al. An imaging flow cytometry-based methodology for the analysis of single extracellular vesicles in unprocessed human plasma. Commun Biol. 2022;5(633):1-14.

W. W. Woud et al., “An imaging flow cytometry-based methodology for the analysis of single extracellular vesicles in unprocessed human plasma,” Commun. Biol., vol. 5, no. 633, pp. 1-14, Jun. 2022.

Woud WW, van der Pol E, Mul E, Hoogduijn MJ, Baan CC, Boer K, et al. An imaging flow cytometry-based methodology for the analysis of single extracellular vesicles in unprocessed human plasma. Commun Biol. 2022 Jun;5(633):1-4.

Nieuwland, R.; Siljander, P. R. M.; Falcón-Pérez, J. M.; Witwer, K. W. Reproducibility of extracellular vesicle research. Eur. J. Cell Biol. 2022, 101 (3), 151226.

Nieuwland R, Siljander PRM, Falcón-Pérez JM, Witwer KW. Reproducibility of extracellular vesicle research. Eur J Cell Biol. 2022;101(3):151226.

R. Nieuwland, P. R. M. Siljander, J. M. Falcón-Pérez, and K. W. Witwer, “Reproducibility of extracellular vesicle research,” Eur. J. Cell Biol., vol. 101, no. 3, pp. 151226, Jun-Aug. 2022.

Nieuwland R, Siljander PRM, Falcón-Pérez JM, Witwer KW. Reproducibility of extracellular vesicle research. Eur J Cell Biol. 2022 Jun-Aug;101(3):151226.

Kim, Y.; van der Pol, E.; Arafi, A.; Thapa, I.; Britton, C.; Kosti, J.; Song, S.; Joshi, V. B.; Erickson, R.; Ali, H.; et al. Calibration and standardization of extracellular vesicle measurements by flow cytometry for translational prostate cancer research. Nanoscale 2022, 14, 9781-9795.

Kim Y, van der Pol E, Arafi A, et al. Calibration and standardization of extracellular vesicle measurements by flow cytometry for translational prostate cancer research. Nanoscale. 2022;14:9781-9795.

Y. Kim et al., “Calibration and standardization of extracellular vesicle measurements by flow cytometry for translational prostate cancer research,” Nanoscale, vol. 14, pp. 9781-9795, May. 2022.

Kim Y, van der Pol E, Arafi A, Thapa I, Britton C, Kosti J, et al. Calibration and standardization of extracellular vesicle measurements by flow cytometry for translational prostate cancer research. Nanoscale. 2022 May;14:9781-95.

Eyileten, C.; Jakubik, D.; Shahzadi, A.; Gąsecka, A.; van der Pol, E.; De Rosa, S.; Siwik, D.; Gajewska, M.; Mirowska-Guzel, D.; Kurkowska-Jastrzębska, I.; et al. Diagnostic performance of circulating miRNAs and extracellular vesicles in acute ischemic stroke. Int. J. Mol. Sci. 2022, 23, 4530.

Eyileten C, Jakubik D, Shahzadi A, et al. Diagnostic performance of circulating miRNAs and extracellular vesicles in acute ischemic stroke. Int J Mol Sci. 2022;23:4530.

C. Eyileten et al., “Diagnostic performance of circulating miRNAs and extracellular vesicles in acute ischemic stroke,” Int. J. Mol. Sci., vol. 23, pp. 4530, Apr. 2022.

Eyileten C, Jakubik D, Shahzadi A, Gąsecka A, van der Pol E, De Rosa S, et al. Diagnostic performance of circulating miRNAs and extracellular vesicles in acute ischemic stroke. Int J Mol Sci. 2022 Apr;23:4530.

Thaler, J.; Lisman, T.; Quehenberger, P.; Hell, L.; Schwabl, P.; Scheiner, B.; Bucsics, T.; Nieuwland, R.; Ay, C.; Trauner, M.; et al. Intraperitoneal activation of coagulation and fibrinolysis in patients with cirrhosis and ascites. Thromb. Haemostasis 2022, 122 (03), 353-362.

Thaler J, Lisman T, Quehenberger P, et al. Intraperitoneal activation of coagulation and fibrinolysis in patients with cirrhosis and ascites. Thromb Haemostasis. 2022;122(03):353-362.

J. Thaler et al., “Intraperitoneal activation of coagulation and fibrinolysis in patients with cirrhosis and ascites,” Thromb. Haemostasis, vol. 122, no. 03, pp. 353-362, Mar. 2022.

Thaler J, Lisman T, Quehenberger P, Hell L, Schwabl P, Scheiner B, et al. Intraperitoneal activation of coagulation and fibrinolysis in patients with cirrhosis and ascites. Thromb Haemostasis. 2022 Mar;122(03):353-362.

Hu, Y.; Kontopodi, E.; Mank, E.; van den Akker, C. H.; van Goudoever, J. B.; Hettinga, K.; van Elburg, R. M.; Thaler, J.; Nieuwland, R. Processing methods of donor human milk evaluated by a blood plasma clotting assay. Innov. Food Sci. Emerg. 2022, 76, 102938.

Hu Y, Kontopodi E, Mank E, et al. Processing methods of donor human milk evaluated by a blood plasma clotting assay. Innov Food Sci Emerg. 2022;76:102938.

Y. Hu et al., “Processing methods of donor human milk evaluated by a blood plasma clotting assay,” Innov. Food Sci. Emerg., vol. 76, pp. 102938, Mar. 2022.

Hu Y, Kontopodi E, Mank E, van den Akker CH, van Goudoever JB, Hettinga K, et al. Processing methods of donor human milk evaluated by a blood plasma clotting assay. Innov Food Sci Emerg. 2022 Mar;76:102938.

van der Pol, E.; Welsh, J. A.; Nieuwland, R. Minimum information to report about a flow cytometry experiment on extracellular vesicles: communication from the ISTH SSC Subcommittee on Vascular Biology. J. Thromb. Haemost. 2022, 20 (1), 245-251.

van der Pol E, Welsh JA, Nieuwland R. Minimum information to report about a flow cytometry experiment on extracellular vesicles: communication from the ISTH SSC Subcommittee on Vascular Biology. J Thromb Haemost. 2022;20(1):245-251.

E. van der Pol, J. A. Welsh, and R. Nieuwland, “Minimum information to report about a flow cytometry experiment on extracellular vesicles: communication from the ISTH SSC Subcommittee on Vascular Biology,” J. Thromb. Haemost., vol. 20, no. 1, pp. 245-251, Jan. 2022.

van der Pol E, Welsh JA, Nieuwland R. Minimum information to report about a flow cytometry experiment on extracellular vesicles: communication from the ISTH SSC Subcommittee on Vascular Biology. J Thromb Haemost. 2022 Jan;20(1):245-51.

van der Pol, E.; van Leeuwen, T. G.; Yan, X. Misinterpretation of solid sphere equivalent refractive index measurements and smallest detectable diameters of extracellular vesicles by flow cytometry. Sci. Rep. 2021, 11, 24151.

van der Pol E, van Leeuwen TG, Yan X. Misinterpretation of solid sphere equivalent refractive index measurements and smallest detectable diameters of extracellular vesicles by flow cytometry. Sci Rep. 2021;11:24151.

E. van der Pol, T. G. van Leeuwen, and X. Yan, “Misinterpretation of solid sphere equivalent refractive index measurements and smallest detectable diameters of extracellular vesicles by flow cytometry,” Sci. Rep., vol. 11, pp. 24151, Dec. 2021.

van der Pol E, van Leeuwen TG, Yan X. Misinterpretation of solid sphere equivalent refractive index measurements and smallest detectable diameters of extracellular vesicles by flow cytometry. Sci Rep. 2021 Dec;11:24151.

Witwer, K. W.; Goberdhan, D. C.; O'Driscoll, L.; Théry, C.; Welsh, J. A.; Blenkiron, C.; Buzás, E. I.; Di Vizio, D.; Erdbrügger, U.; Falcón-Pérez, J. M.; et al. Updating MISEV: Evolving the minimal requirements for studies of extracellular vesicles. J. Extracell. Vesicles 2021, 10 (14), e12182.

Witwer KW, Goberdhan DC, O'Driscoll L, et al. Updating MISEV: Evolving the minimal requirements for studies of extracellular vesicles. J Extracell Vesicles. 2021;10(14):e12182.

K. W. Witwer et al., “Updating MISEV: Evolving the minimal requirements for studies of extracellular vesicles,” J. Extracell. Vesicles, vol. 10, no. 14, pp. e12182, Dec. 2021.

Witwer KW, Goberdhan DC, O'Driscoll L, Théry C, Welsh JA, Blenkiron C, et al. Updating MISEV: Evolving the minimal requirements for studies of extracellular vesicles. J Extracell Vesicles. 2021 Dec;10(14):e12182.

Hu, Y.; Thaler, J.; Nieuwland, R. Extracellular Vesicles in Human Milk. Pharmaceuticals 2021, 14 (10), 1050.

Hu Y, Thaler J, Nieuwland R. Extracellular Vesicles in Human Milk. Pharmaceuticals. 2021;14(10):1050.

Y. Hu, J. Thaler, and R. Nieuwland, “Extracellular Vesicles in Human Milk,” Pharmaceuticals, vol. 14, no. 10, pp. 1050, Oct. 2021.

Hu Y, Thaler J, Nieuwland R. Extracellular Vesicles in Human Milk. Pharmaceuticals. 2021 Oct;14(10):1050.

Léopold, V.; Pereverzeva, L.; Schuurman, A. R.; Reijnders, T. D.; Saris, A.; de Brabander, J.; van Linge, C. C.; Douma, R. A.; Chouchane, O.; Nieuwland, R.; et al. Platelets are hyperactivated but show reduced glycoprotein VI reactivity in COVID-19 patients. Thromb. Haemostasis 2021, 121 (09), 1258-1262.

Léopold V, Pereverzeva L, Schuurman AR, et al. Platelets are hyperactivated but show reduced glycoprotein VI reactivity in COVID-19 patients. Thromb Haemostasis. 2021;121(09):1258-1262.

V. Léopold et al., “Platelets are hyperactivated but show reduced glycoprotein VI reactivity in COVID-19 patients,” Thromb. Haemostasis, vol. 121, no. 09, pp. 1258-1262, Sep. 2021.

Léopold V, Pereverzeva L, Schuurman AR, Reijnders TD, Saris A, de Brabander J, et al. Platelets are hyperactivated but show reduced glycoprotein VI reactivity in COVID-19 patients. Thromb Haemostasis. 2021 Sep;121(09):1258-1262.

Gholampour, M. A.; Abroun, S.; Nieuwland, R.; Mowla, S. J.; Soudi, S. Mesenchymal stem cell-derived extracellular vesicles conditionally ameliorate bone marrow failure symptoms in an immune-mediated aplastic anemia mouse model. J. Cell. Physiol. 2021, 236 (8), 6055-6067.

Gholampour MA, Abroun S, Nieuwland R, Mowla SJ, Soudi S. Mesenchymal stem cell-derived extracellular vesicles conditionally ameliorate bone marrow failure symptoms in an immune-mediated aplastic anemia mouse model. J Cell Physiol. 2021;236(8):6055-6067.

M. A. Gholampour, S. Abroun, R. Nieuwland, S. J. Mowla, and S. Soudi, “Mesenchymal stem cell-derived extracellular vesicles conditionally ameliorate bone marrow failure symptoms in an immune-mediated aplastic anemia mouse model,” J. Cell. Physiol., vol. 236, no. 8, pp. 6055-6067, Aug. 2021.

Gholampour MA, Abroun S, Nieuwland R, Mowla SJ, Soudi S. Mesenchymal stem cell-derived extracellular vesicles conditionally ameliorate bone marrow failure symptoms in an immune-mediated aplastic anemia mouse model. J Cell Physiol. 2021 Aug;236(8):6055-6067.

Florijn, B. W.; Duijs, J. M. G. J.; Klaver, M.; Kuipers, E. N.; Kooijman, S.; Prins, J.; Zhang, H.; Sips, H. C. M.; Stam, W.; Hanegraaf, M.; et al. Estradiol-driven metabolism in transwomen associates with reduced circulating extracellular vesicle microRNA-224/452. Eur. J. Endocrinol. 2021, 185 (4), 539-552.

Florijn BW, Duijs JMGJ, Klaver M, et al. Estradiol-driven metabolism in transwomen associates with reduced circulating extracellular vesicle microRNA-224/452. Eur J Endocrinol. 2021;185(4):539-552.

B. W. Florijn et al., “Estradiol-driven metabolism in transwomen associates with reduced circulating extracellular vesicle microRNA-224/452,” Eur. J. Endocrinol., vol. 185, no. 4, pp. 539-552, Aug. 2021.

Florijn BW, Duijs JMGJ, Klaver M, Kuipers EN, Kooijman S, Prins J, et al. Estradiol-driven metabolism in transwomen associates with reduced circulating extracellular vesicle microRNA-224/452. Eur J Endocrinol. 2021 Aug;185(4):539-552.

de Rond, L.; Coumans, F. A.; Welsh, J. A.; Nieuwland, R.; Leeuwen, T. G.; van der Pol, E. Quantification of light scattering detection efficiency and background in flow cytometry. Cytom. Part A 2021, 99 (7), 671-679.

de Rond L, Coumans FA, Welsh JA, Nieuwland R, Leeuwen TG, van der Pol E. Quantification of light scattering detection efficiency and background in flow cytometry. Cytom Part A. 2021;99(7):671-679.

L. de Rond, F. A. Coumans, J. A. Welsh, R. Nieuwland, T. G. Leeuwen, and E. van der Pol, “Quantification of light scattering detection efficiency and background in flow cytometry,” Cytom. Part A, vol. 99, no. 7, pp. 671-679, Jul. 2021.

de Rond L, Coumans FA, Welsh JA, Nieuwland R, Leeuwen TG, van der Pol E. Quantification of light scattering detection efficiency and background in flow cytometry. Cytom Part A. 2021 Jul;99(7):671-9.

Slapak, E. J.; Kong, L.; El Mandili, M.; Nieuwland, R.; Kros, A.; Bijlsma, M. F.; Spek, C. A. ADAM9-Responsive mesoporous silica nanoparticles for targeted drug delivery in pancreatic cancer. Cancers 2021, 13 (13), 3321.

Slapak EJ, Kong L, El Mandili M, et al. ADAM9-Responsive mesoporous silica nanoparticles for targeted drug delivery in pancreatic cancer. Cancers. 2021;13(13):3321.

E. J. Slapak et al., “ADAM9-Responsive mesoporous silica nanoparticles for targeted drug delivery in pancreatic cancer,” Cancers, vol. 13, no. 13, pp. 3321, Jul. 2021.

Slapak EJ, Kong L, El Mandili M, Nieuwland R, Kros A, Bijlsma MF, et al. ADAM9-Responsive mesoporous silica nanoparticles for targeted drug delivery in pancreatic cancer. Cancers. 2021 Jul;13(13):3321.

Nieuwland, R. Novel mechanism regulating tissue factor activity. Blood 2021, 138 (4), 289-291.

Nieuwland R. Novel mechanism regulating tissue factor activity. Blood. 2021;138(4):289-291.

R. Nieuwland, “Novel mechanism regulating tissue factor activity,” Blood, vol. 138, no. 4, pp. 289-291, Jul. 2021.

Nieuwland R. Novel mechanism regulating tissue factor activity. Blood. 2021 Jul;138(4):289-291.

Rikkert, L. G.; Coumans, F. A.; Hau, C. M.; Terstappen, L. W.; Nieuwland, R. Platelet removal by single-step centrifugation. Platelets 2021, 32 (4), 440-443.

Rikkert LG, Coumans FA, Hau CM, Terstappen LW, Nieuwland R. Platelet removal by single-step centrifugation. Platelets. 2021;32(4):440-443.

L. G. Rikkert, F. A. Coumans, C. M. Hau, L. W. Terstappen, and R. Nieuwland, “Platelet removal by single-step centrifugation,” Platelets, vol. 32, no. 4, pp. 440-443, May. 2021.

Rikkert LG, Coumans FA, Hau CM, Terstappen LW, Nieuwland R. Platelet removal by single-step centrifugation. Platelets. 2021 May;32(4):440-443.

Welsh, J. A.; Tang, V. A.; van der Pol, E.; Görgens, A. MIFlowCyt-EV: The next chapter in the reporting and reliability of single extracellular vesicle flow cytometry experiments. Cytom. Part A 2021, 99 (4), 365-368.

Welsh JA, Tang VA, van der Pol E, Görgens A. MIFlowCyt-EV: The next chapter in the reporting and reliability of single extracellular vesicle flow cytometry experiments. Cytom Part A. 2021;99(4):365-368.

J. A. Welsh, V. A. Tang, E. van der Pol, and A. Görgens, “MIFlowCyt-EV: The next chapter in the reporting and reliability of single extracellular vesicle flow cytometry experiments,” Cytom. Part A, vol. 99, no. 4, pp. 365-368, Apr. 2021.

Welsh JA, Tang VA, van der Pol E, Görgens A. MIFlowCyt-EV: The next chapter in the reporting and reliability of single extracellular vesicle flow cytometry experiments. Cytom Part A. 2021 Apr;99(4):365-8.

Sogorb-Gonzalez, M.; Vendrell-Tornero, C.; Snapper, J.; Stam, A.; Keskin, S.; Miniarikova, J.; Spronck, E. A.; de Haan, M.; Nieuwland, R.; Konstantinova, P.; et al. Secreted therapeutics: monitoring durability of microRNA-based gene therapies in the central nervous system. Brain Commun. 2021, 3 (2), fcab054.

Sogorb-Gonzalez M, Vendrell-Tornero C, Snapper J, et al. Secreted therapeutics: monitoring durability of microRNA-based gene therapies in the central nervous system. Brain Commun. 2021;3(2):fcab054.

M. Sogorb-Gonzalez et al., “Secreted therapeutics: monitoring durability of microRNA-based gene therapies in the central nervous system,” Brain Commun., vol. 3, no. 2, pp. fcab054, Apr. 2021.

Sogorb-Gonzalez M, Vendrell-Tornero C, Snapper J, Stam A, Keskin S, Miniarikova J, et al. Secreted therapeutics: monitoring durability of microRNA-based gene therapies in the central nervous system. Brain Commun. 2021 Apr;3(2):fcab054.

Cimorelli, M.; Nieuwland, R.; Varga, Z.; van der Pol, E. Standardized procedure to measure the size distribution of extracellular vesicles together with other particles in biofluids with microfluidic resistive pulse sensing. Plos One 2021, 16 (4), e0249603.

Cimorelli M, Nieuwland R, Varga Z, van der Pol E. Standardized procedure to measure the size distribution of extracellular vesicles together with other particles in biofluids with microfluidic resistive pulse sensing. Plos One. 2021;16(4):e0249603.

M. Cimorelli, R. Nieuwland, Z. Varga, and E. van der Pol, “Standardized procedure to measure the size distribution of extracellular vesicles together with other particles in biofluids with microfluidic resistive pulse sensing,” Plos One, vol. 16, no. 4, pp. e0249603, Apr. 2021.

Cimorelli M, Nieuwland R, Varga Z, van der Pol E. Standardized procedure to measure the size distribution of extracellular vesicles together with other particles in biofluids with microfluidic resistive pulse sensing. Plos One. 2021 Apr;16(4):e0249603.